NMDP℠ Raises More Than $235,000 at Annual LA Gala Fundraiser
August 13, 2024 10:00 ET
|
NMDP
NMDP recently hosted its annual gala in Los Angeles to raise critical funds that support patient financial assistance and innovation in cell therapy.
Bionano Announces Presentation of Optical Genome Mapping Utility Across Cancer Research Applications at the Cancer Genomics Consortium (CGC) 2024 Annual Meeting
August 01, 2024 08:00 ET
|
Bionano Genomics
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- A sponsored exhibitor session will feature Dr. Phillip Michaels from Harvard Medical School and Brigham and Women’s Hospital presenting data from a...
Bionano Announces Publication of First Multi-Site Study to Analyze the Utility of OGM in Multiple Myeloma
July 23, 2024 08:00 ET
|
Bionano Genomics
SAN DIEGO, July 23, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the publication of the first multi-site study in multiple myeloma (MM) comparing optical genome...
Scientific Presentations Highlight OGM’s Utility for Cancer Research at Joint Annual Meeting for Three Molecular and Cytogenetic Associations
July 02, 2024 08:00 ET
|
Bionano Laboratories
At a sponsored workshop, Su Yang from The University of Texas MD Anderson Cancer Center will present case studies that demonstrate the ability of the optical genome mapping (OGM) workflow to detect...
ExCellThera Announces EMA’s Acceptance under Accelerated Assessment of Market Authorisation Application (MAA) for UM171 Cell Therapy for Patients with Hematological Malignancies who Lack a Readily Available Suitable Donor
June 25, 2024 07:00 ET
|
ExCellThera
Market Authorisation Application (MAA) for ExCellThera's UM171 Cell Therapy accepted under accelerated assessment by the European Medicines Agency
Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis
June 17, 2024 16:05 ET
|
Bionano Laboratories
American Medical Association issues Category I CPT code for the use of optical genome mapping in genome-wide analysis related to hematological malignancies
Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update
May 09, 2024 16:05 ET
|
Vor Biopharma
On-track for trem-cel and VCAR33ALLO clinical updates in the second half of 2024Trem-cel trial expanded to include patients with myelodysplastic syndromes (MDS); Mylotarg™ dosing has advanced to the...
Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Saving Cell Therapy
May 08, 2024 14:46 ET
|
NMDP
The annual NMDP Gala in New York raises critical funds, enabling more patients to receive life-saving cell therapy.
International Myeloma Foundation Holds 15th Annual Gala at the Edison Ballroom in New York City on April 18
April 25, 2024 08:45 ET
|
International Myeloma Foundation
On April 18, the International Myeloma Foundation held its 15th Annual Gala at the Edison Ballroom for the first time in New York, hosted by Ray Romano.
Lifelong Philanthropist and 17-year Myeloma Survivor John O’Dwyer Elected to the International Myeloma Foundation’s Board of Directors
March 14, 2024 08:45 ET
|
International Myeloma Foundation
STUDIO CITY, Calif. , March 14, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is thrilled to welcome lifelong philanthropist and 17-year myeloma survivor John O’Dwyer to the...